SPINK9 rabbit pAb
Product details
Background:
Specifications
| Size | 50μL/100μL |
| Target | SPINK9 |
| Reactivity | Human |
| Applications | WB |
| MW(Calculated) | 9kD |
| MW(Observed) | |
| Host Species | Rabbit |
| Isotype | IgG |
| Conjugate/Modification | Unmodified |
| Recommended Dilution Ratio | WB 1:500-2000 |
| Formulation | Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. |
| Storage | -15°C to -25°C/1 year(Do not lower than -25°C) |
| Concentration | 1 mg/ml |
| Clonality | Polyclonal |
| Clone Number | |
| Immunogen | Synthesized peptide derived from human SPINK9 |
| Specificity | This antibody detects endogenous levels of SPINK9 at Human |
| Gene Name | SPINK9 LEKTI2 |
| Protein Name | Serine protease inhibitor Kazal-type 9 (Lymphoepithelial Kazal-type-related inhibitor 2) |
| Other Name | |
| Species | Human |
| Gene ID | 643394 |
| Uniprot | Q5DT21 |
| Species.1 | |
| Gene ID.1 | |
| Uniprot.1 | |
| Species.2 | |
| Gene ID.2 | |
| Uniprot.2 | |
| Cellular Localization | Secreted . |
| Tissue Expression | Skin. Highly expressed at sites of hyperkeratosis. Also detected in thymus, tonsils, testis, pancreas, liver, placenta and brain. Expressed at stratum granulosum and stratum corneum at palmar and plantar sites (at protein level). |
| Signaling_pathway | |
| Research Areas | |
| Function | Serine protease inhibitor which specifically inhibits KLK5. May contribute to the regulation of the desquamation process in skin by inhibiting KLK5. |
Please login to post questions






